<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39434842</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0024-3639</ISSN><JournalIssue CitedMedium="Print"><Volume>91</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Linacre quarterly</Title><ISOAbbreviation>Linacre Q</ISOAbbreviation></Journal><ArticleTitle>Validation of Ethical COVID-19 Antibody Testing that Adheres to Pro-Life Principles.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>442</EndPage><MedlinePgn>435-442</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00243639241258538</ELocationID><Abstract><AbstractText>We describe validation of a COVID-19 antibody test for detection of anti-SARS-CoV-2 receptor-binding domain (RBD) IgG antibodies in blood plasma utilizing ethically sourced reagents not derived from aborted fetal cell lines. The test demonstrated specificity of 100% (95% confidence intervals 77.2-100%) and sensitivity of 100% (95% confidence intervals 79.6-100%) when evaluating blood specimens previously determined to be negative (<i>n</i> = 13) or positive for anti-SARS-CoV-2 RBD IgG antibodies due to natural SARS-CoV-2 exposure (<i>n</i> = 13) or COVID-19 vaccination (<i>n</i> = 15). The test was used to screen 230 blood specimens from individuals with unknown SARS-CoV-2 exposure (<i>n</i> = 103) or that were naturally exposed to SARS-CoV-2 (<i>n</i> = 44), received a COVID-19 vaccine (<i>n</i> = 66), or received a COVID-19 vaccine before or after SARS-CoV-2 exposure (<i>n</i> = 17). Ninety-nine percent (95% confidence intervals 95.7-100%) of the 127 blood specimens from individuals that were naturally exposed, vaccinated, or both vaccinated and naturally exposed were positive for anti-SARS-CoV-2 RBD IgG which was consistent with the high sensitivity of our test. This COVID-19 antibody test, now named the PL COVID-19 RBD IgG antibody test, represents an effective and ethical alternative to commercially available COVID-19 antibody tests that utilize reagents derived from aborted fetal lines.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McKenna</LastName><ForeName>Kyle C</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0001-6235-411X</Identifier><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohall</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kissinger</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nick</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calkins</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Franciscan University of Steubenville, Steubenville, OH, USA.</Affiliation><Identifier Source="RINGGOLD">7615</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Linacre Q</MedlineTA><NlmUniqueID>2985221R</NlmUniqueID><ISSNLinking>0024-3639</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abortion</Keyword><Keyword MajorTopicYN="N">bioethics</Keyword><Keyword MajorTopicYN="N">catholic identity in health care</Keyword><Keyword MajorTopicYN="N">conscience in medicine</Keyword><Keyword MajorTopicYN="N">cooperation with evil</Keyword><Keyword MajorTopicYN="N">difficult moral questions</Keyword><Keyword MajorTopicYN="N">faith and science</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434842</ArticleId><ArticleId IdType="pmc">PMC11490964</ArticleId><ArticleId IdType="doi">10.1177/00243639241258538</ArticleId><ArticleId IdType="pii">10.1177_00243639241258538</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biotechne/R&amp;D Systems. 2023. “COVID-Seroindex, Kantaro SARS-CoV-2 IgG Antibody RUO Kit Datasheet.” https://www.rndsystems.com/products/covid-seroindex-kantaro-sars-cov-2-igg-antibody-ruo-kit_dsr200</Citation></Reference><Reference><Citation>Boyton R. J., Altman D. A.. 2021. “The Immunology of Asymptomatic SARS-CoV-2 Infection: What Are the Key Questions?” Nature Reviews Immunology 21 (12): 762–768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525456</ArticleId><ArticleId IdType="pubmed">34667307</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown L., Cai T., DasGupta A.. 2001. “Interval Estimation for a Binomial Proportion.” Statistical Science 16 (2): 101–133.</Citation></Reference><Reference><Citation>CDC. 2023. “CDC Museum and COVID-19 timeline.” https://www.cdc.gov/museum/timeline/covid19.html</Citation></Reference><Reference><Citation>Ladaria, L. F., and G. Morandi. 2021. “Congregation for the Doctrine of the Faith: Note on the Morality of Using Some Anti-COVID-19 Vaccines.” Linacre Q 88 (3): 254–255. 10.1177/00243639211014987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00243639211014987</ArticleId><ArticleId IdType="pmc">PMC8375374</ArticleId><ArticleId IdType="pubmed">34565900</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers J., Windau Anne, Schmotzer Christine, Saade Elie, Noguez Jaime, Stempak Lisa, Zhang Xiaochun, et al. 2022. “SARS-CoV-2 Antibody Profile of Naturally Infected and Vaccinated Individuals Detected Using Qualitative, Semi-quantitative and Multiplex Immunoassays.” Diagn Microbiol Infect Dis 104 (4): 115803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9420072</ArticleId><ArticleId IdType="pubmed">36162282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontifical Academy for Life. 2019. “Pontifical Academy for Life Statement: Moral Reflections on Vaccines Prepared from Cells Derived from Aborted Human Foetuses.” Linacre Q 86 (2–3): 182–187. 10.1177/0024363919855896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0024363919855896</ArticleId><ArticleId IdType="pmc">PMC6699053</ArticleId><ArticleId IdType="pubmed">32431408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades K. C., Naumann J. F.. 2020. “Moral considerations regarding the new COVID-19 vaccines. Chairmen of the Committee on Doctrine and the Committee on Pro-Life Activities United States Conference of Catholic Bishops.” https://www.usccb.org/resources/moral-considerations-covid-vaccines.pdf</Citation></Reference><Reference><Citation>Rohall M., Kissinger D., Evans M., Wright E., Nick E., Calkins M., Burton D., McKenna K. C.. 2022. “Development of Ethical COVID-19 Antibody Testing that Adheres to Pro-Life Principles.” Linacre Q 10.1177/00243639221095906</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00243639221095906</ArticleId><ArticleId IdType="pmc">PMC11490964</ArticleId><ArticleId IdType="pubmed">39434842</ArticleId></ArticleIdList></Reference><Reference><Citation>USFDA. 2023. “Independent Evaluations of COVID-19 Serological Tests.” https://open.fda.gov/apis/device/covid19serology/</Citation></Reference><Reference><Citation>Wadman M. 2020. “Vaccines That Use Human Fetal Cells Draw Fire.” Science 368 (6496): 1170–1171. 10.1126/science.368.6496.1170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.368.6496.1170</ArticleId><ArticleId IdType="pubmed">32527809</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>